[Meta] the regain rule is doing its job and people should stop complaining
Housekeeping: the regain rule is doing its job and people should stop complaining.
The two levers, described properly, because this board mixes them up constantly.
Reducing the dose lowers average exposure while keeping the weekly rhythm. Stretching the interval keeps the dose but lowers the trough between injections, which — with a week-long half-life — is why people notice appetite returning towards the end of a stretched cycle before they see anything on the scale.
The reported pattern here is stretching in small steps, a week to ten days to twelve, with appetite as the signal rather than the scale. Some people find dose reduction more comfortable. Neither is a schedule anybody here can hand you, and the fact that this phase has the least published guidance is exactly why board consensus deserves less weight than usual.
Withdrawal studies in this class consistently show substantial regain after discontinuation. That is a pharmacological finding about a chronic condition, not a statement about anyone’s discipline.
Interval stretching changes the exposure profile: with a week-long half-life, moving to ten or twelve days lowers trough concentration more than it lowers average exposure. That is why appetite return is often the first thing noticed.
Tell me where this is wrong. That is the useful part of posting it.
best — the order this archive was captured in
Maintenance is the phase with the least published guidance and the most individual variation, which is precisely why board consensus here is worth less than usual.
Stretched from seven to ten days and then to twelve over about four months. Appetite told me where the limit was before the scale did.
the habits are the part that has to outlive the dose
Appetite returning before the scale moves follows from the mechanism: the appetite effect is the proximal one and weight is the lagging integrated outcome.
Body weight varies by a couple of kilos over days in stable people through fluid, glycogen and gut content. A range is not a trend.
Correction: that trial measured regain after withdrawal, not failure of the drug during treatment. Very different claim.
What is the plan if the drift continues for another month?
the lowest effective dose is a real target and nobody talks about it